Publication
Cover of publication

Market Access as the Key to Chinese Pharmaceuticals

Portrait of Yoshihiro Suwa
Partner
Jakarta Office, Southeast Asia
+62 21 8063-7050
June 30, 2014

This study examines the Chinese pharmaceuticals market – a sector that has steadily posted solid and swift growth at an annual clip exceeding 20% in recent years.

1. China Already a Top Market

  • As of 2012, the Chinese pharmaceuticals market was No. 3 in the world. By 2020, it is expected to rise to No. 2.
  • The Chinese market in these products offers higher profitability than its counterparts in developed nations.

2. Shifting from “Sales-Driven Marketing” to “Market Access”

  • The end of the era of sales supported by quantitative superiority and sheer sales strength.
  • Meticulous market access to regional governments holds the key to success from here on.

3. Demands for Precision Market Grasp

  • Sizing up markets through local products.
  • Spot-on assessment of business opportunities.

blue background
Think:Act

Hiyaku: Market Access as the Key to Chinese Pharmaceuticals

{[downloads[language].preview]}

This study examines the Chinese pharmaceuticals market.

Published June 2014. Available in